Jubilant Ingrevia Limited Delivers Strong Q1 FY27 Performance: Net Profit Soars 41% YoY to ₹105.82 Crore

Jubilant Ingrevia Limited has announced its consolidated unaudited financial results for the first quarter ended June 30, 2026 (Q1 FY27). The company recorded robust top-line and bottom-line growth, driven by solid execution across its key operating segments, with notable momentum in Speciality Chemicals and Chemical Intermediates.

Executive Financial Summary

Revenue from Operations: Climbed 25% YoY to ₹1,300.27 crore in Q1 FY27 compared to ₹1,037.87 crore in Q1 FY26. Sequentially, revenue increased 10% QoQ from ₹1,178.65 crore in Q4 FY26.

Other Income: Came in at ₹10.22 crore for the quarter, compared to ₹11.30 crore in Q1 FY26 (-10% YoY) and ₹9.31 crore in Q4 FY26 (+10% QoQ).

Total Income: Grew 25% YoY to ₹1,310.49 crore in Q1 FY27 from ₹1,049.17 crore in Q1 FY26, and expanded 10% QoQ over ₹1,187.96 crore recorded in Q4 FY26.

Total Expenses: Stood at ₹1,169.60 crore in Q1 FY27, up 23% YoY from ₹949.34 crore in Q1 FY26 and up 9% QoQ from ₹1,076.23 crore in Q4 FY26.

Profit Before Tax (PBT): Rose 41% YoY to ₹140.86 crore in Q1 FY27 versus ₹99.77 crore in Q1 FY26. On a quarter-on-quarter basis, PBT increased 26% QoQ from ₹111.71 crore in Q4 FY26.

Tax Expense: Stood at ₹35.04 crore for Q1 FY27, compared to ₹24.67 crore in Q1 FY26 (+42% YoY) and ₹25.27 crore in Q4 FY26 (+39% QoQ).

Net Profit (PAT): Surged 41% YoY to ₹105.82 crore in Q1 FY27 compared to ₹75.10 crore in Q1 FY26. Sequentially, net profit expanded 22% QoQ from ₹86.44 crore in Q4 FY26.

Diluted Earnings Per Share (EPS): Increased 41% YoY to ₹6.68 per share for Q1 FY27 from ₹4.75 in Q1 FY26 and ₹5.39 in Q4 FY26 (+24% QoQ).

Segment-Wise Operational Performance

1. Speciality Chemicals

Gross Segment Revenue: Stood at ₹637.00 crore in Q1 FY27, growing 19% YoY compared to ₹536.97 crore in Q1 FY26 and 5% QoQ from ₹603.67 crore in Q4 FY26.

Segment Profitability (PBIT): Grew 3% YoY to ₹109.14 crore compared to ₹106.23 crore in Q1 FY26, while dropping slightly by 3% QoQ from ₹112.93 crore in Q4 FY26.

2. Nutrition & Health Solutions

Gross Segment Revenue: Reached ₹243.82 crore in Q1 FY27, up 36% YoY from ₹178.87 crore in Q1 FY26 and up 6% QoQ from ₹230.28 crore in Q4 FY26.

Segment Profitability (PBIT): Surged 41% YoY to ₹28.26 crore compared to ₹19.99 crore in Q1 FY26, and expanded 10% QoQ from ₹25.79 crore in Q4 FY26.

3. Chemical Intermediates

Gross Segment Revenue: Rose 38% YoY to ₹525.17 crore in Q1 FY27 from ₹381.57 crore in Q1 FY26, registering a 21% QoQ growth over ₹434.52 crore in Q4 FY26.

Segment Profitability (PBIT): Experienced a massive turnaround, jumping 785% YoY to ₹43.97 crore compared to ₹4.97 crore in Q1 FY26 and soaring 698% QoQ from ₹5.51 crore in Q4 FY26.

Margin Expansion & Balance Sheet Metrics

Operating Margin: Expanded to 11.39% in Q1 FY27, up from 9.76% in Q1 FY26 and 9.69% in Q4 FY26.

Net Profit Margin: Improved to 8.07% in Q1 FY27 versus 7.16% in Q1 FY26 and 7.28% in Q4 FY26.

Debt to Equity Ratio: Stood comfortable at 0.22x as of June 30, 2026.

Interest Service Coverage Ratio (ISCR): Maintained strong coverage at 12.01x.

Debt Service Coverage Ratio (DSCR): Reached 4.81x.

Net Worth: Rose to ₹3,241.45 crore as on June 30, 2026, compared to ₹3,015.01 crore as on June 30, 2025.

Shares of Jubilant Ingrevia Limited was last trading in BSE at Rs. 764.25 as compared to the previous close of Rs. 736.65. The total number of shares traded during the day was 50139 in over 2137 trades.

The stock hit an intraday high of Rs. 772.50 and intraday low of 742.45. The net turnover during the day was Rs. 38339085.00.

Source : Equity Bulls

Keywords

JubilantIngrevia INE0BY001018 Q1FY27 Q1FY2027 ResultUpdate